Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer
Objectives18F-fluorodeoxyglucose (FDG) PET/CT has been widely used in tumor diagnosis, staging, and response evaluation. To determine an optimal therapeutic strategy for lung cancer patients, accurate staging is essential. Semi-quantitative standardized uptake value (SUV) is known to be affected by...
Main Authors: | Xieraili Wumener, Yarong Zhang, Zhenguo Wang, Maoqun Zhang, Zihan Zang, Bin Huang, Ming Liu, Shengyun Huang, Yong Huang, Peng Wang, Ying Liang, Tao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1005924/full |
Similar Items
-
Case Report of Prostate Cancer Patient with Only Lymph Node Involvement on F-18 FDG PET/CT
by: Hyun Jin Jung, et al.
Published: (2018-12-01) -
The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
by: Xuhe Liao, et al.
Published: (2023-04-01) -
Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
by: Yuan Hu, et al.
Published: (2023-03-01) -
Added Value of Abnormal Lymph Nodes Detected with FDG-PET/CT in Suspected Vascular Graft Infection
by: Nick D. van Rijsewijk, et al.
Published: (2023-02-01) -
Head-to-head comparison of 18F-FDG PET/CT and 18F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a meta-analysis
by: Min Zhang, et al.
Published: (2024-03-01)